首页 > 最新文献

Archivos Peruanos de cardiologia y cirugia cardiovascular最新文献

英文 中文
[Epidemiological characteristics of heart transplant recipients in Peru 2010-2020]. 【2010-2020年秘鲁心脏移植受者的流行病学特征】。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.187
Gracia Del Carmen Polo Lecca, Franz Ronald Soplopuco Palacios, Walter Alberto Alarco León, Oscar Nelson Aguirre Zurita, Cristian Aguilar Carranza, Ruth Eneida Villarroel Villa, Tommy Leonel Prado Gómez, José Luis Tapia Leonardo, Miguel Ángel Lescano Alva, Víctor Justo Robles Velarde, Julio Alberto Morón Castro, Yulma Donayre Moquillaza, Teresa Colque Rojas, Luis Javier Palma Ortecho, David Germán Gálvez Caballero

Objective: To evaluate the epidemiological, clinical, surgical, pathological characteristics and outcomes in the follow-up of heart transplant recipients at the National Cardiovascular Institute during 2010-2020.

Material and methods: A retrospective descriptive study was performed by reviewing the medical records of patients undergoing heart transplantation at a national referral center, describing the clinical, surgical, laboratory, pathology characteristics and survival of patients up to 10 years of follow-up.

Results: Eighty-six patients were transplanted in 10 years, the median age was 41 years (RIQ 28-56), being predominantly male (66.3%). The three leading causes of indication for heart transplantation were: dilated cardiomyopathy (48.9%), ischemic heart disease (17.4%), and myocarditis (6.9%). Total ischemia time was 160 minutes (RIQ 129.7-233.5). Survival at one, five, and ten years was 84.8%, 73.6%, and 65.7% respectively. The main cause of death was non-cardiac: infectious (39.1%) and of unknown origin (26%).

Conclusions: The main etiology of heart failure in heart transplant recipients in Peru in recent years was nonischemic dilated cardiomyopathy. We observed that the survival rate was similar to that of international registries; however, the rate of mortality due to infectious causes and death of unknown origin is high, which poses a challenge in the management of post-transplant patients.

目的:评估2010-2020年美国国家心血管研究所心脏移植受者的流行病学、临床、外科、病理学特征和随访结果。材料和方法:通过回顾在国家转诊中心接受心脏移植的患者的病历,进行回顾性描述性研究,描述了患者的临床、外科、实验室、病理特征和长达10年的随访。结果:86名患者在10年内被移植,中位年龄为41岁(RIQ 28-56),主要是男性(66.3%)。心脏移植指征的三个主要原因是:扩张型心肌病(48.9%)、缺血性心脏病(17.4%),总缺血时间为160分钟(RIQ 129.7-233.5),1年、5年和10年生存率分别为84.8%、73.6%和65.7%。主要死因为非心脏性:传染性(39.1%)和不明原因(26%)。结论:近年来秘鲁心脏移植受者心力衰竭的主要病因是非缺血性扩张型心肌病。我们观察到,存活率与国际登记处的存活率相似;然而,由于感染原因和不明原因死亡的死亡率很高,这对移植后患者的管理提出了挑战。
{"title":"[Epidemiological characteristics of heart transplant recipients in Peru 2010-2020].","authors":"Gracia Del Carmen Polo Lecca,&nbsp;Franz Ronald Soplopuco Palacios,&nbsp;Walter Alberto Alarco León,&nbsp;Oscar Nelson Aguirre Zurita,&nbsp;Cristian Aguilar Carranza,&nbsp;Ruth Eneida Villarroel Villa,&nbsp;Tommy Leonel Prado Gómez,&nbsp;José Luis Tapia Leonardo,&nbsp;Miguel Ángel Lescano Alva,&nbsp;Víctor Justo Robles Velarde,&nbsp;Julio Alberto Morón Castro,&nbsp;Yulma Donayre Moquillaza,&nbsp;Teresa Colque Rojas,&nbsp;Luis Javier Palma Ortecho,&nbsp;David Germán Gálvez Caballero","doi":"10.47487/apcyccv.v2i4.187","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.187","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the epidemiological, clinical, surgical, pathological characteristics and outcomes in the follow-up of heart transplant recipients at the National Cardiovascular Institute during 2010-2020.</p><p><strong>Material and methods: </strong>A retrospective descriptive study was performed by reviewing the medical records of patients undergoing heart transplantation at a national referral center, describing the clinical, surgical, laboratory, pathology characteristics and survival of patients up to 10 years of follow-up.</p><p><strong>Results: </strong>Eighty-six patients were transplanted in 10 years, the median age was 41 years (RIQ 28-56), being predominantly male (66.3%). The three leading causes of indication for heart transplantation were: dilated cardiomyopathy (48.9%), ischemic heart disease (17.4%), and myocarditis (6.9%). Total ischemia time was 160 minutes (RIQ 129.7-233.5). Survival at one, five, and ten years was 84.8%, 73.6%, and 65.7% respectively. The main cause of death was non-cardiac: infectious (39.1%) and of unknown origin (26%).</p><p><strong>Conclusions: </strong>The main etiology of heart failure in heart transplant recipients in Peru in recent years was nonischemic dilated cardiomyopathy. We observed that the survival rate was similar to that of international registries; however, the rate of mortality due to infectious causes and death of unknown origin is high, which poses a challenge in the management of post-transplant patients.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"233-239"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/7e/apcyccv-2-233.PMC10506564.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41145634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulmonary arterial hypertension and renal impairment in patients from the National Institute of Cardiology Dr. Ignacio Chávez, Mexico]. [墨西哥国家心脏病研究所Ignacio Chávez博士的患者肺动脉高压和肾损伤]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.150
Franklyn Colón, Anthony Gutiérrez, Annette G García, Lorgis Jiménez, Diego E Arbaje, Nayeli Zayas

Objective: The objective of the study was to describe the clinical characteristics and the evolution of the severity of pulmonary arterial hypertension (PAH) and the degree of renal failure.

Material and methods: A retrospective observational study was carried out in which the physical and electronic medical records of 60 patients older than 18 years with a diagnosis of pulmonary arterial hypertension were analyzed.

Results: In our study, 11.4% of the severe PAH group worsened renal function at six months, and 13.6% of the participants worsened it at one year. In contrast, in the group with moderate PAH, 18.8% worsened at six months, and 12.5% worsened at one year. Also, the GFR at one year was 54.15 mL/min/1.73 m2 in the moderate PAH group and in the severe PAH group was 73.55 mL/min/1.73 m2.

Conclusion: The results of this research suggest that the deterioration of kidney function is related to the severity of pulmonary arterial hypertension.

目的:本研究旨在描述肺动脉高压(PAH)的临床特征、严重程度和肾功能衰竭程度的演变。材料和方法:进行了一项回顾性观察研究,分析了60名18岁以上诊断为肺动脉高压的患者的物理和电子病历。结果:在我们的研究中,11.4%的严重PAH组在6个月时肾功能恶化,13.6%的参与者在1年时肾功能加重。相反,在中度PAH组中,18.8%在6个月时恶化,12.5%在1年时恶化。此外,中度PAH组一年时的GFR为54.15 mL/min/1.73 m2,重度PAH组为73.55 mL/min/1.76 m2。结论:本研究结果表明,肾功能恶化与肺动脉高压的严重程度有关。
{"title":"[Pulmonary arterial hypertension and renal impairment in patients from the National Institute of Cardiology Dr. Ignacio Chávez, Mexico].","authors":"Franklyn Colón,&nbsp;Anthony Gutiérrez,&nbsp;Annette G García,&nbsp;Lorgis Jiménez,&nbsp;Diego E Arbaje,&nbsp;Nayeli Zayas","doi":"10.47487/apcyccv.v2i4.150","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.150","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the study was to describe the clinical characteristics and the evolution of the severity of pulmonary arterial hypertension (PAH) and the degree of renal failure.</p><p><strong>Material and methods: </strong>A retrospective observational study was carried out in which the physical and electronic medical records of 60 patients older than 18 years with a diagnosis of pulmonary arterial hypertension were analyzed.</p><p><strong>Results: </strong>In our study, 11.4% of the severe PAH group worsened renal function at six months, and 13.6% of the participants worsened it at one year. In contrast, in the group with moderate PAH, 18.8% worsened at six months, and 12.5% worsened at one year. Also, the GFR at one year was 54.15 mL/min/1.73 m<sup>2</sup> in the moderate PAH group and in the severe PAH group was 73.55 mL/min/1.73 m<sup>2</sup>.</p><p><strong>Conclusion: </strong>The results of this research suggest that the deterioration of kidney function is related to the severity of pulmonary arterial hypertension.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"240-246"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/de/apcyccv-2-240.PMC10506565.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41177502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Stanford type A aortic dissection associated with aortic coarctation repaired by Tirone E. David & debranching techniques with combined axillar and femoral perfusion: a case report. Tirone E.David和去支技术结合腋窝和股骨灌注修复与主动脉缩窄相关的急性斯坦福A型主动脉夹层:一例报告。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.154
Francisco Guerrero, Karla Bautista, Giuseppe Salas, Edmy Callalli, Josías C Ríos

We present the case of a 38-year-old male with a diagnosis of Stanford A aortic dissection and associated coarctation of the thoracic aorta. Acute dissection associated with coarctation of the aorta is a rare problem and difficult to manage surgically. Establishing a cardiopulmonary bypass (CPB) with adequate flows is the main objective of the procedure; optimal cannulation ensures the protection of cerebral and visceral organs. We successfully performed aortic valve re-implantation surgery (T. David Surgery), replacement of the ascending aorta and aortic arch, as well as debranching of the supra-aortic trunks. The cannulation technique was axillary and femoral to guarantee flows through the coarctation area.

我们报告一例38岁男性,诊断为Stanford a主动脉夹层和相关的胸主动脉缩窄。与主动脉缩窄相关的急性夹层是一个罕见的问题,很难通过手术治疗。建立具有足够流量的体外循环(CPB)是该程序的主要目标;最佳插管可确保对大脑和内脏器官的保护。我们成功地进行了主动脉瓣再植入手术(T.David surgery),置换了升主动脉和主动脉弓,并清除了主动脉上干的分支。插管技术是腋窝和股骨,以保证通过缩窄区的流量。
{"title":"Acute Stanford type A aortic dissection associated with aortic coarctation repaired by Tirone E. David & debranching techniques with combined axillar and femoral perfusion: a case report.","authors":"Francisco Guerrero,&nbsp;Karla Bautista,&nbsp;Giuseppe Salas,&nbsp;Edmy Callalli,&nbsp;Josías C Ríos","doi":"10.47487/apcyccv.v2i3.154","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.154","url":null,"abstract":"<p><p>We present the case of a 38-year-old male with a diagnosis of Stanford A aortic dissection and associated coarctation of the thoracic aorta. Acute dissection associated with coarctation of the aorta is a rare problem and difficult to manage surgically. Establishing a cardiopulmonary bypass (CPB) with adequate flows is the main objective of the procedure; optimal cannulation ensures the protection of cerebral and visceral organs. We successfully performed aortic valve re-implantation surgery (T. David Surgery), replacement of the ascending aorta and aortic arch, as well as debranching of the supra-aortic trunks. The cannulation technique was axillary and femoral to guarantee flows through the coarctation area.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"211-215"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/20/apcyccv-2-211.PMC10506551.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bibliometric analysis of peruvian scientific production in cardiology and cardiovascular medicine]. [秘鲁心脏病学和心血管医学科学成果的文献计量分析]。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.157
Rodrigo Vargas-Fernández, Fabriccio J Visconti-Lopez, Francisco A Barón-Lozada, Gianfranco W Basualdo-Meléndez

Objective: To determine the characteristics and trend of the articles published on cardiology and cardiovascular medicine in the Peruvian context, and to understand how it has changed over the years.

Materials and methods: A bibliometric study of original articles published up to 2020 by Peruvian authors in journals indexed under the category "Cardiac & Cardiovascular Systems" in Web of Science (WOS) was performed. The articles were included according to the selection criteria in the Rayyan web application and the bibliometric analysis was performed using the Bibliometrix package in the R programming language and VOSviewer.

Results: A total of 159 published articles were included, and an increase in the number of publications since 2015 was observed. The most cited article was a clinical trial by Fitchett et al. and published in 2016. Miranda JJ was the Peruvian author with the highest number of published articles followed by Hernández AV and Málaga G. The institutional affiliation with the highest number of original articles was Universidad Peruana Cayetano Heredia. Regarding the terms or keywords, it was found that most of the published studies had terms related to epidemiology, while in the most recent articles, the terms were related to outcomes or specific interventions that are used in clinical studies.

Conclusions: In the last five years, there has been an increase in the scientific production on cardiology and cardiovascular medicine by authors with Peruvian institutional affiliation, with a greater production from the Universidad Peruana Cayetano Heredia. The journal with the highest number of publications by authors with Peruvian institutional affiliation on cardiology and cardiovascular medicine was Circulation, where two of the most cited articles with Peruvian institutional affiliation were also found.

目的:确定秘鲁背景下发表的关于心脏病学和心血管医学的文章的特点和趋势,并了解这些年来的变化。材料和方法:对秘鲁作者截至2020年在科学网(WOS)“心脏与心血管系统”类期刊上发表的原创文章进行了文献计量学研究。这些文章是根据Rayyan web应用程序中的选择标准收录的,并使用R编程语言和VOSviewer中的Bibliometrix包进行文献计量分析。结果:共收录159篇已发表的文章,自2015年以来,发表的文章数量有所增加。引用最多的文章是Fitchett等人于2016年发表的一项临床试验。Miranda JJ是发表文章最多的秘鲁作家,其次是Hernández AV和Málaga G.。原创文章最多的机构是Peruana Cayetano Heredia大学。关于术语或关键词,发现大多数已发表的研究都有与流行病学有关的术语,而在最近的文章中,这些术语与临床研究中使用的结果或具体干预措施有关。结论:在过去五年中,与秘鲁机构有联系的作者在心脏病学和心血管医学方面的科学成果有所增加,其中秘鲁卡耶塔诺·埃雷迪亚大学的成果更大。与秘鲁机构有联系的作者在心脏病学和心血管医学方面发表的文章数量最多的期刊是《循环》,其中还发现了两篇被引用最多的秘鲁机构文章。
{"title":"[Bibliometric analysis of peruvian scientific production in cardiology and cardiovascular medicine].","authors":"Rodrigo Vargas-Fernández,&nbsp;Fabriccio J Visconti-Lopez,&nbsp;Francisco A Barón-Lozada,&nbsp;Gianfranco W Basualdo-Meléndez","doi":"10.47487/apcyccv.v2i3.157","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.157","url":null,"abstract":"<p><strong>Objective: </strong>To determine the characteristics and trend of the articles published on cardiology and cardiovascular medicine in the Peruvian context, and to understand how it has changed over the years.</p><p><strong>Materials and methods: </strong>A bibliometric study of original articles published up to 2020 by Peruvian authors in journals indexed under the category \"Cardiac & Cardiovascular Systems\" in Web of Science (WOS) was performed. The articles were included according to the selection criteria in the Rayyan web application and the bibliometric analysis was performed using the Bibliometrix package in the R programming language and VOSviewer.</p><p><strong>Results: </strong>A total of 159 published articles were included, and an increase in the number of publications since 2015 was observed. The most cited article was a clinical trial by Fitchett <i>et al</i>. and published in 2016. Miranda JJ was the Peruvian author with the highest number of published articles followed by Hernández AV and Málaga G. The institutional affiliation with the highest number of original articles was Universidad Peruana Cayetano Heredia. Regarding the terms or keywords, it was found that most of the published studies had terms related to epidemiology, while in the most recent articles, the terms were related to outcomes or specific interventions that are used in clinical studies.</p><p><strong>Conclusions: </strong>In the last five years, there has been an increase in the scientific production on cardiology and cardiovascular medicine by authors with Peruvian institutional affiliation, with a greater production from the Universidad Peruana Cayetano Heredia. The journal with the highest number of publications by authors with Peruvian institutional affiliation on cardiology and cardiovascular medicine was Circulation, where two of the most cited articles with Peruvian institutional affiliation were also found.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"167-174"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/6a/apcyccv-2-167.PMC10506556.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41123155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
[Congenital heart disease associated with the most prevalent chromosomal syndromes: a literature review]. [与最常见染色体综合征相关的先天性心脏病:文献综述]。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.155
José Eduardo Castillo Lam, Oscar Eduardo Elías Adauto, Gian Paolo Huamán Benancio

Most frequent chromosomal syndromes like Down, Patau, Edwards, Turner, and Williams affect the pediatric population in various ways, and congenital heart disease explains the altered quality of life they suffer. There is a lack of studies reviewing the cardiac anomalies in these syndromes, and the ones that exist are publications from past decades. We reviewed databases such as MEDLINE, LILACS, SCIELO, and Google Scholar, selecting the best possible evidence, and each chromosomal syndrome was investigated in relation to congenital heart disease, constituting five search groups. The article shows the characteristics of each heart disease described in the studies reviewed, the author, date of publication, country, and population studied, as well as a brief description of the frequency of the disease and its mortality. The results described in this review were contrasted with previous existing literature to verify if there was correspondence between the reported frequencies. The most frequent congenital heart diseases were atrioventricular septal defect (AVSD), ventricular septal defect (VSD), atrial septal defect (ASD), and persistent ductus arteriosus (PDA) in Down syndrome patients, PDA, ASD, and VSD in Patau syndrome patients, AVSD, PDA and valvular defects in Edwards syndrome, bicuspid aortic valve, aortic coarctation and aortic stenosis in Turner syndrome, and supravalvular aortic stenosis and pulmonary stenosis in Williams syndrome.

唐、帕托、爱德华兹、特纳和威廉姆斯等最常见的染色体综合征以各种方式影响儿科人群,先天性心脏病解释了他们生活质量的改变。目前缺乏对这些综合征中心脏异常的研究,现有的研究都是过去几十年的出版物。我们审查了MEDLINE、LILACS、SCIELO和Google Scholar等数据库,选择了可能的最佳证据,并调查了与先天性心脏病相关的每种染色体综合征,组成了五个搜索组。这篇文章展示了所综述的研究中描述的每种心脏病的特征、作者、发表日期、国家和研究人群,并简要描述了该疾病的频率及其死亡率。将本综述中描述的结果与以前的现有文献进行对比,以验证报告的频率之间是否存在对应关系。唐氏综合征患者最常见的先天性心脏病是房室间隔缺损(AVSD)、室间隔缺损(VSD)、房间隔缺损(ASD)和持续性动脉导管(PDA),帕托综合征患者为PDA、ASD和VSD,Edwards综合征为AVSD、PDA和瓣膜缺陷,Turner综合征为双叶主动脉瓣、主动脉缩窄和主动脉狭窄,Williams综合征的主动脉瓣上狭窄和肺动脉狭窄。
{"title":"[Congenital heart disease associated with the most prevalent chromosomal syndromes: a literature review].","authors":"José Eduardo Castillo Lam,&nbsp;Oscar Eduardo Elías Adauto,&nbsp;Gian Paolo Huamán Benancio","doi":"10.47487/apcyccv.v2i3.155","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.155","url":null,"abstract":"<p><p>Most frequent chromosomal syndromes like Down, Patau, Edwards, Turner, and Williams affect the pediatric population in various ways, and congenital heart disease explains the altered quality of life they suffer. There is a lack of studies reviewing the cardiac anomalies in these syndromes, and the ones that exist are publications from past decades. We reviewed databases such as MEDLINE, LILACS, SCIELO, and Google Scholar, selecting the best possible evidence, and each chromosomal syndrome was investigated in relation to congenital heart disease, constituting five search groups. The article shows the characteristics of each heart disease described in the studies reviewed, the author, date of publication, country, and population studied, as well as a brief description of the frequency of the disease and its mortality. The results described in this review were contrasted with previous existing literature to verify if there was correspondence between the reported frequencies. The most frequent congenital heart diseases were atrioventricular septal defect (AVSD), ventricular septal defect (VSD), atrial septal defect (ASD), and persistent ductus arteriosus (PDA) in Down syndrome patients, PDA, ASD, and VSD in Patau syndrome patients, AVSD, PDA and valvular defects in Edwards syndrome, bicuspid aortic valve, aortic coarctation and aortic stenosis in Turner syndrome, and supravalvular aortic stenosis and pulmonary stenosis in Williams syndrome.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"187-195"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/69/apcyccv-2-187.PMC10506540.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Invasive hemodynamic monitoring by Swan-Ganz pulmonary artery catheter: concepts and utility]. 【Swan-Ganz肺动脉导管有创血流动力学监测:概念和实用性】。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.152
José María Carrasco Rueda, Giorgio André Gabino Gonzalez, José Luis Sánchez Cachi, Roberto Pedro Pariona Canchiz, Anghella Fiorela Valdivia Gómez, Oscar Nelson Aguirre Zurita

Since its beginnings in the last century, pulmonary artery catheterization (PAC) has evolved into an invasive hemodynamic evaluation technique that can be performed at the patient's bedside through a Swan-Ganz catheter; this procedure has maintained an intermittent course in terms of its use; however, it has currently demonstrated relevance in specific scenarios. The PAC allows access to the central venous circulation, the right heart and the pulmonary artery; it performs the calculation of hemodynamic variables directly or indirectly by means of established formulas and methods. This makes possible to perform an adequate hemodynamic evaluation and classification, perform specific tests (e.g. vasoreactivity test), which help to define the diagnosis, therapeutic , monitor the response to treatment, evaluation prior to advanced therapies (e.g. cardiac transplantation or mechanical circulatory assistance devices), and prognosis in our patients. In this article we discuss the concepts and usefulness of pulmonary artery catheterization.

自上个世纪开始以来,肺动脉导管插入术(PAC)已经发展成为一种有创的血液动力学评估技术,可以通过Swan-Ganz导管在患者床边进行;就其使用而言,该程序保持了间歇性过程;然而,它目前已证明在特定情况下具有相关性。PAC允许进入中央静脉循环、右心和肺动脉;它通过建立的公式和方法直接或间接地计算血液动力学变量。这使得进行充分的血液动力学评估和分类、进行特定的测试(如血管反应性测试)成为可能,这些测试有助于确定我们患者的诊断、治疗、监测对治疗的反应、高级治疗(如心脏移植或机械循环辅助装置)前的评估以及预后。在这篇文章中,我们讨论了肺动脉插管的概念和作用。
{"title":"[Invasive hemodynamic monitoring by Swan-Ganz pulmonary artery catheter: concepts and utility].","authors":"José María Carrasco Rueda,&nbsp;Giorgio André Gabino Gonzalez,&nbsp;José Luis Sánchez Cachi,&nbsp;Roberto Pedro Pariona Canchiz,&nbsp;Anghella Fiorela Valdivia Gómez,&nbsp;Oscar Nelson Aguirre Zurita","doi":"10.47487/apcyccv.v2i3.152","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.152","url":null,"abstract":"<p><p>Since its beginnings in the last century, pulmonary artery catheterization (PAC) has evolved into an invasive hemodynamic evaluation technique that can be performed at the patient's bedside through a Swan-Ganz catheter; this procedure has maintained an intermittent course in terms of its use; however, it has currently demonstrated relevance in specific scenarios. The PAC allows access to the central venous circulation, the right heart and the pulmonary artery; it performs the calculation of hemodynamic variables directly or indirectly by means of established formulas and methods. This makes possible to perform an adequate hemodynamic evaluation and classification, perform specific tests (e.g. vasoreactivity test), which help to define the diagnosis, therapeutic , monitor the response to treatment, evaluation prior to advanced therapies (e.g. cardiac transplantation or mechanical circulatory assistance devices), and prognosis in our patients. In this article we discuss the concepts and usefulness of pulmonary artery catheterization.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"175-186"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/76/apcyccv-2-175.PMC10506572.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Valve thrombosis and thrombolytic therapy in modern era: a case report]. 【现代瓣膜血栓形成及溶栓治疗1例报告】。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.149
Oswaldo E Aguilar-Molina, David Prada-Escobar, Jairo A Gándara-Ricardo, Héctor D Arroyave-Páramo, Juan M Senior-Sánchez, Edison Muñoz-Ortiz

Prosthetic valve thrombosis is a feared complication with an annual incidence ranging between 0.3 to 1.3%. Diagnostic approach is essential for a better prognosis and ultimately determines the chosen therapeutic strategy. Emergent valvular surgery is usually recommended in hemodinamically unstable patients, large thrombus or recurrent embolic episodes. These high-risk conditions are often not the case. Therefore, in many patients the surgical risk is much greater than that of bleeding associated with thrombolytic administration. Ultra-slow infusions have been reported with similar efficacy and lower rates of bleeding complications. We present a case of mitral prosthetic valve thrombosis considered not feasible to surgical management and subsequently treated with an ultra-slow tissue plasminogen activator infusion.

人工瓣膜血栓形成是一种令人担忧的并发症,年发病率在0.3%至1.3%之间。诊断方法对于更好的预后至关重要,并最终决定所选择的治疗策略。对于血液不稳定、大血栓或复发性栓塞的患者,通常建议进行紧急瓣膜手术。这些高风险的情况往往并非如此。因此,在许多患者中,手术风险远大于与溶栓给药相关的出血风险。据报道,超慢速输注具有相似的疗效和较低的出血并发症发生率。我们报告了一例二尖瓣人工瓣膜血栓形成,认为手术治疗不可行,随后用超慢速组织纤溶酶原激活剂输注治疗。
{"title":"[Valve thrombosis and thrombolytic therapy in modern era: a case report].","authors":"Oswaldo E Aguilar-Molina, David Prada-Escobar, Jairo A Gándara-Ricardo, Héctor D Arroyave-Páramo, Juan M Senior-Sánchez, Edison Muñoz-Ortiz","doi":"10.47487/apcyccv.v2i3.149","DOIUrl":"10.47487/apcyccv.v2i3.149","url":null,"abstract":"<p><p>Prosthetic valve thrombosis is a feared complication with an annual incidence ranging between 0.3 to 1.3%. Diagnostic approach is essential for a better prognosis and ultimately determines the chosen therapeutic strategy. Emergent valvular surgery is usually recommended in hemodinamically unstable patients, large thrombus or recurrent embolic episodes. These high-risk conditions are often not the case. Therefore, in many patients the surgical risk is much greater than that of bleeding associated with thrombolytic administration. Ultra-slow infusions have been reported with similar efficacy and lower rates of bleeding complications. We present a case of mitral prosthetic valve thrombosis considered not feasible to surgical management and subsequently treated with an ultra-slow tissue plasminogen activator infusion.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"196-199"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/e6/apcyccv-2-196.PMC10506549.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41174897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Stuck valve leaflet detected by 3D transesophageal echocardiography]. 【三维经食道超声心动图检测到瓣叶卡住】。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.144
Roberto Baltodano-Arellano, Kelly Cupe-Chacalcaje, Ángela Cachicatari-Beltrán
{"title":"[Stuck valve leaflet detected by 3D transesophageal echocardiography].","authors":"Roberto Baltodano-Arellano,&nbsp;Kelly Cupe-Chacalcaje,&nbsp;Ángela Cachicatari-Beltrán","doi":"10.47487/apcyccv.v2i3.144","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.144","url":null,"abstract":"","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"216-218"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/f7/apcyccv-2-216.PMC10506567.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41180550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Catecholaminergic polymorphic ventricular tachycardia in adolescents: a clinical, electrocardiographic and genetic diagnosis]. [青少年儿茶酚胺能多态性室性心动过速的临床、心电图和遗传诊断]。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.151
María Concepción Rocha-Arrieta, Antonio Arias-Díaz, Carlos Alberto Quiróz-Romero, Yermis Rocha-Arrieta

Catecholaminergic polymorphic ventricular tachycardia is one of the most lethal channelopathies, characterized by ventricular arrhythmias triggered by stress or physical activity. We present the case of an adolescent who consulted for recurrent syncope precipitated by exercise. In the diagnostic approach, catecholaminergic polymorphic ventricular tachycardia was reached, with a mutation in the cardiac ryanodine receptor gene, Heterozygous c.14311G> A (p.v4771I exon 100), antiarrhythmic drugs and implantable cardioverter-defibrillator were necessary with satisfactory evolution. Clinical suspicion, stress test and genetic tests are essential for a timely diagnosis and management of this pathology.

儿茶酚胺能多态性室性心动过速是最致命的通道病之一,其特征是由压力或身体活动引发的室性心律失常。我们报告了一个青少年因运动诱发的复发性晕厥咨询的病例。在诊断方法中,达到了儿茶酚胺能多态性室性心动过速,心脏ryanodine受体基因发生突变,杂合c.14311G>a(p.v4771I外显子100),抗心律失常药物和植入式心律转复除颤器是必要的,并有令人满意的发展。临床怀疑、压力测试和基因测试对于及时诊断和管理这种病理至关重要。
{"title":"[Catecholaminergic polymorphic ventricular tachycardia in adolescents: a clinical, electrocardiographic and genetic diagnosis].","authors":"María Concepción Rocha-Arrieta,&nbsp;Antonio Arias-Díaz,&nbsp;Carlos Alberto Quiróz-Romero,&nbsp;Yermis Rocha-Arrieta","doi":"10.47487/apcyccv.v2i3.151","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.151","url":null,"abstract":"<p><p>Catecholaminergic polymorphic ventricular tachycardia is one of the most lethal channelopathies, characterized by ventricular arrhythmias triggered by stress or physical activity. We present the case of an adolescent who consulted for recurrent syncope precipitated by exercise. In the diagnostic approach, catecholaminergic polymorphic ventricular tachycardia was reached, with a mutation in the cardiac ryanodine receptor gene, Heterozygous c.14311G> A (p.v4771I exon 100), antiarrhythmic drugs and implantable cardioverter-defibrillator were necessary with satisfactory evolution. Clinical suspicion, stress test and genetic tests are essential for a timely diagnosis and management of this pathology.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"205-210"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/ef/apcyccv-2-205.PMC10506566.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41124377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ablation of cardiac arrhythmias using a three-dimensional electro-anatomical mapping system in the Instituto Nacional Cardiovascular - INCOR]. [使用国家心血管研究所-INCOR的三维电解剖标测系统消融心律失常]。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.147
Richard Soto-Becerra, Álvaro Taype-Rondan, Mario Cabrera-Saldaña, Carolina Guevara-Caicedo, Pio D Zelaya-Castro, José M Medina-Maguiña, Rocío E Huerta-Robles, Wendy Junes-Gonzales, Ofelia Aráoz-Tarco, Alejandro Sangines-Montes, Ricardo Zegarra-Carhuas

Objective: To describe the initial experience in ablation of cardiac arrhythmias using 3D mapping at the Instituto Nacional Cardiovascular INCOR (Lima, Peru).

Methods: A retrospective descriptive study was carried out. During February 2020, data was collected from the medical records of all patients in whom ablation was performed using 3D mapping from July 2017 to December 2019. This procedure was performed in patients with symptomatic arrhythmia refractory to antiarrhythmic therapy.

Results: Data were collected from 123 patients (median age: 46 years, 64.2% male), who had a median time of illness of 6 years. Among the arrhythmias treated, 19% had atrial fibrillation, 17.5% atrial tachycardia, 17.5% idiopathic ventricular arrhythmias, 16.6% Wolf Parkinson White syndrome / Atrioventricular reentrant tachycardia, 11.1% ventricular arrhythmias of the His-Purkinje conduction system, 9.5% scar related ventricular tachycardia associated, 6.4% atrial flutter and 2.4% intranodal tachycardia. The median fluoroscopy time was 26 minutes. Ablation was acutely successful in 95.9% of cases, acute complications were observed in 4.8%, and recurrence-free survival during the first year of follow-up was 74%.

Conclusions: Our experience in ablation of cardiac arrhythmias using 3D mapping had a high acute success rate, low frequency of complications, and one-year recurrence-free survival of 74 %.

目的:描述在国家心血管研究所(秘鲁利马)使用3D标测消融心律失常的初步经验。方法:采用回顾性描述性研究。2020年2月,从2017年7月至2019年12月使用3D标测进行消融的所有患者的医疗记录中收集数据。该手术是在抗心律失常治疗难治的症状性心律失常患者中进行的。结果:数据收集自123名患者(中位年龄:46岁,64.2%为男性),他们的中位患病时间为6年。在接受治疗的心律失常中,19%的心律失常为心房颤动,17.5%的房性心动过速,17.5%为特发性室性心律失常,16.6%为Wolf-Parkinson-White综合征/房室折返性心动过快,11.1%为His-Purkinje传导系统室性心律不整,9.5%为瘢痕相关室性心动过过速,6.4%为房扑,2.4%为节内心动过速。荧光镜检查时间中位数为26分钟。95.9%的病例急性成功消融,4.8%的病例观察到急性并发症,随访第一年的无复发生存率为74%。结论:我们使用三维标测消融心律失常的经验具有较高的急性成功率、较低的并发症发生率和74%的一年无复发生存率。
{"title":"[Ablation of cardiac arrhythmias using a three-dimensional electro-anatomical mapping system in the Instituto Nacional Cardiovascular - INCOR].","authors":"Richard Soto-Becerra,&nbsp;Álvaro Taype-Rondan,&nbsp;Mario Cabrera-Saldaña,&nbsp;Carolina Guevara-Caicedo,&nbsp;Pio D Zelaya-Castro,&nbsp;José M Medina-Maguiña,&nbsp;Rocío E Huerta-Robles,&nbsp;Wendy Junes-Gonzales,&nbsp;Ofelia Aráoz-Tarco,&nbsp;Alejandro Sangines-Montes,&nbsp;Ricardo Zegarra-Carhuas","doi":"10.47487/apcyccv.v2i3.147","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.147","url":null,"abstract":"<p><strong>Objective: </strong>To describe the initial experience in ablation of cardiac arrhythmias using 3D mapping at the Instituto Nacional Cardiovascular INCOR (Lima, Peru).</p><p><strong>Methods: </strong>A retrospective descriptive study was carried out. During February 2020, data was collected from the medical records of all patients in whom ablation was performed using 3D mapping from July 2017 to December 2019. This procedure was performed in patients with symptomatic arrhythmia refractory to antiarrhythmic therapy.</p><p><strong>Results: </strong>Data were collected from 123 patients (median age: 46 years, 64.2% male), who had a median time of illness of 6 years. Among the arrhythmias treated, 19% had atrial fibrillation, 17.5% atrial tachycardia, 17.5% idiopathic ventricular arrhythmias, 16.6% Wolf Parkinson White syndrome / Atrioventricular reentrant tachycardia, 11.1% ventricular arrhythmias of the His-Purkinje conduction system, 9.5% scar related ventricular tachycardia associated, 6.4% atrial flutter and 2.4% intranodal tachycardia. The median fluoroscopy time was 26 minutes. Ablation was acutely successful in 95.9% of cases, acute complications were observed in 4.8%, and recurrence-free survival during the first year of follow-up was 74%.</p><p><strong>Conclusions: </strong>Our experience in ablation of cardiac arrhythmias using 3D mapping had a high acute success rate, low frequency of complications, and one-year recurrence-free survival of 74 %.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"150-158"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/68/apcyccv-2-150.PMC10506558.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41157274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Archivos Peruanos de cardiologia y cirugia cardiovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1